European and Developing Countries Clinical Trials Partnership (EDCTP)
European and Developing Countries Clinical Trials Partnership (EDCTP)
Explore linked clinical trials.15 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People Living With HIV-1 Infection | HIV-1-infection | Recruiting | Phase 3 | 2026-07-27 | NCT06203132 | |
| Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neuroinflammatory Diseases, Tuberculosis, Central Nervous System, Tuberculosis, Extrapulmonary, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, gram-positive bacterial infections, meningeal tuberculosis, meningitis, mycobacterial infectious disease, nervous system disorder, tuberculosis | Recruiting | Phase 3 | 2026-06-24 | NCT04145258 | |
| Evaluating the Impact of Computer-assisted X-ray Diagnosis and Other Triage Tools to Optimise Xpert Orientated Community-based Active Case Finding for TB and COVID-19 | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Blood-Borne Infections, COVID-19, Coronaviridae Infections, Genital Diseases, HIV infectious disease, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, Urogenital Diseases, bacterial infectious disease, gram-positive bacterial infections, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, lung disorder, mycobacterial infectious disease, pneumonia, respiratory system disorder, respiratory tract infectious disorder, sexually transmitted disease, tuberculosis, uterine carcinosarcoma, viral infectious disease, viral pneumonia, viral sexually transmitted disease | Active, not recruiting | Not applicable | 2026-05-08 | NCT05220163 | |
| Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, smallpox, viral infectious disease | Active, not recruiting | Phase 3 | 2026-04-29 | NCT06844487 | |
| The DECIDE-TB Trial; Validation of Treatment Decision Algorithms for Childhood Tuberculosis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, Nutritional and Metabolic Diseases, Severe Acute Malnutrition, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease, nutritional deficiency disease, nutritional disorder, tuberculosis | Recruiting | Not applicable | 2026-03-24 | NCT06593080 | |
| A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 With Matrix-M in Combination With R21/Matrix-M | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Active, not recruiting | Phase 2 | 2026-03-11 | NCT07183371 | |
| A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 Combined With R21/Matrix-M (a "Multi-stage" Malaria Vaccine) | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Phase 1 | 2026-03-11 | NCT06958198 | |
| Assessing the Safety, Immunogenicity and Ex-vivo Efficacy of Two Candidate Malaria Transmission Blocking Vaccines, Pfs25-IMX313 and Pfs45/48 Administered Alone and in Combination, in Matrix-M Adjuvant | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Active, not recruiting | Phase 1 / Phase 2 | 2026-02-23 | NCT06549257 | |
| Phase 3 Maternal Safety & Immunogenicity Trial of MVA-BN® in DRC | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, smallpox, viral infectious disease | Active, not recruiting | Phase 3 | 2026-01-30 | NCT06844500 | |
| A Study to Assess Immune Response Status in Patients Before and After Treatment for Visceral Leishmaniasis | Euglenozoa Infections, Infections, leishmaniasis, parasitic infectious disease, protozoa infectious disease, vector-borne disease, visceral leishmaniasis | Active, not recruiting | Not stated | 2025-07-24 | NCT04342715 | |
| Epidemiological and Pathophysiological Insights Through a Cross-sectional Survey (EPIC) | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Recruiting | Not stated | 2025-05-02 | NCT06840860 | |
| A Study to Test Experimental Blood Stage Malaria Vaccine in Burkina Faso. | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Phase 1 / Phase 2 | 2025-03-07 | NCT05790889 | |
| Lassa Fever Clinical Course and Prognostic Factors in Nigeria | Arenaviridae infectious disease, Coma, Consciousness Disorders, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Infections, Lassa fever, Male Urogenital Diseases, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Signs and Symptoms, Unconsciousness, Urogenital Diseases, acute kidney injury, kidney disorder, kidney failure, nervous system disorder, pregnancy disorder, urinary system disorder, viral hemorrhagic fever, viral infectious disease | Active, not recruiting | Not stated | 2025-01-29 | NCT03655561 | |
| Host Blood RNA Signatures for Diagnosis of TB | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease, tuberculosis | Active, not recruiting | Not stated | 2024-12-16 | NCT05542511 | |
| InvaplexAR-Detox and DmLT Adjuvant in the Netherlands and Zambia | Bacterial Infections and Mycoses, Digestive System Diseases, Enterobacteriaceae Infections, Infections, bacterial infectious disease, digestive system disorder, dysentery, gastroenteritis, gram-negative bacterial infections, intestinal disorder, shigellosis | Recruiting | Phase 1 | 2024-11-07 | NCT05961059 |